Global Atorvastatin Calcium Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
According to our (Global Info Research) latest study, the global Atorvastatin Calcium market size was valued at USD 225.3 million in 2022 and is forecast to a readjusted size of USD 366.1 million by 2029 with a CAGR of 7.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The key players of global Atorvastatin Calcium include Pfizer, DSM Sinochem Pharmaceuticals, Ind-Swift, Cadila Pharmaceuticals, Morepen and Sun Pharmaceutical Industries. Pfizer is the leader of this industry with about 26% market shares. India and China are the main consumption bases, and India holds 35% consumption share, and China holds 18% consumption share. They occupy 54% of the global consumption in total.
This report is a detailed and comprehensive analysis for global Atorvastatin Calcium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Atorvastatin Calcium market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (K USD/MT), 2018-2029
Global Atorvastatin Calcium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (K USD/MT), 2018-2029
Global Atorvastatin Calcium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (K USD/MT), 2018-2029
Global Atorvastatin Calcium market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (K USD/MT), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Atorvastatin Calcium
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Atorvastatin Calcium market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, DSM Sinochem Pharmaceuticals, Ind-Swift, Cadila Pharmaceuticals and Morepen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Atorvastatin Calcium market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Chemical Synthesis
    Biocatalysis
Market segment by Application
    Tablet (Including Dispersible Tablet and General Tablet)
    Capsule
    Others
Major players covered
    Pfizer
    DSM Sinochem Pharmaceuticals
    Ind-Swift
    Cadila Pharmaceuticals
    Morepen
    Sun Pharmaceutical Industries
    MSN Laboratories
    Dr. Reddy's
    Teva Pharmaceutical Industries
    Apotex Pharmachem
    Zheijang Neo-Dankon Pharmaceutical
    Ningbo Menovo Pharmaceuticals Group
    Jialin Pharmaceutical
    Topfond
    Zhejiang Hisun Pharmacutical
    Zhejiang Hongyuan Pharmaceutical
    Hubei Yitai Pharmaceutical
    Jiangsu Hengrui Medicine
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Atorvastatin Calcium product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Atorvastatin Calcium, with price, sales, revenue and global market share of Atorvastatin Calcium from 2018 to 2023.
Chapter 3, the Atorvastatin Calcium competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Atorvastatin Calcium breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Atorvastatin Calcium market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Atorvastatin Calcium.
Chapter 14 and 15, to describe Atorvastatin Calcium sales channel, distributors, customers, research findings and conclusion.